About CARE™
The CARE™ Faculty is recognizing its 15th year in 20/20 with education programming in a number of disease categories.
We develop education initiatives directed at our peers, nurses, pharmacists, patients, government and private payers.
LEARN MORE
Recent Publications
The 15th annual CARE™ at ASH Meeting was virtually streamed on Friday, December 4th 2020. The event had a lineup of leading Canadian hematologists contextualize key news and data from the ASH 2020 Conference.
View Publication
Hematology
CARE™ at ASH 2020 Report
Hematology
CHC West 2020 Report
On behalf of the CARE™ hematology faculty and our CHC-WEST chair Dr. Carolyn Owen, we are pleased to present CHC-WEST 2020. After reviewing the presentations from CHC national, various faculty have provided additional Western Canadian perspectives. Click on the topics below to the access the session summaries and Western perspectives. More faculty perspectives coming soon!
View Publication
Au nom du comité académique de CARETM sur l’hématologie et de notre président de la Conférence canadienne sur l’hématologie (CCH-QC), le Dr Dennis Claude Roy, nous sommes heureux de vous présenter la CCH-QC.
View Publication
Hematology
CCH-QC 2020 Résumé de la séance
Hematology
CHC 2020 Report
This year marks the 10th annual Canadian Hematology Conference (CHC), presented virtually for the first time ever! Over the past 10 years, CHC has become the largest multi-disciplinary hematological conference across Canada, bringing together over 150 pan-Canadian and International speakers to showcase cutting-edge research and developments in the field of hematology.
View Publication
This year, the American Society of Clinical Oncology (ASCO) hosted a virtual conference. Members of the CARE™ Faculties attended the virtual meeting reviewing the most compelling stories and news presented in different areas of Oncology.
Members of the CARE™ Steering Faculties have come together to create COVID-19 Guidances covering considerations for patient management and treatment during the COVID-19 era.
